http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0218580-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df5016d32b888add7211643738680620 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate | 2001-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e816399765cd83db319989a1c995a3d |
publicationDate | 2002-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-0218580-A2 |
titleOfInvention | 54372, a novel human anion transporter and uses therefor |
abstract | The invention provides isolated nucleic acids molecules, designated 54372 nucleic acid molecules, which encode novel transporter family members, preferably anion transporter. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 54372 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 54372 gene has been introduced or disrupted. The invention still further provides isolated 54372 proteins, fusion proteins, antigenic peptides and anti-54372 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
priorityDate | 2000-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 845.